参考文献/References:
［1］ Gérard JP, Conroy T, Bonnetain F, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203［J］. J Clin Oncol, 2006, 24: 4620-4625.
［2］ 黄小艳， 余进进， 潘 敏， 等. 3-溴丙酮酸对人宫颈癌HeLa细胞增殖的抑制作用［J］. 现代肿瘤医学， 2012， 20： 921-924.
［3］ 易长虹， 袁琳波， 钱 坤， 等． 肝动脉灌注3-溴丙酮酸阻断大鼠肝癌能量代谢的实验研究［J］． 介入放射学杂志， 2013， 22： 1027-1032．
［4］ 蒋蔚茹， 刘 杰． 结直肠癌化疗进展［J］． 中国肿瘤， 2011， 20： 200-203．
［5］ De Paoli A, Innocente R, Buonadonna A, et al. Neoadjuvant therapy of rectal cancer New treatment perspectives［J］. Tumori, 2004, 90: 373-378.
［6］ Gwak GY, Yoon JH, Kim KM, et al. Hypoxia stimulates proliferation of human hepatoma cells through the induction of hexokinase II expression［J］. J Hepatol, 2005, 42: 358-364.
［7］ Vossen JA, Buijs M, Syed L, et al. Development of a new orthotopic animal model of metastatic liver cancer in the rabbit VX2 model: effect on meta stases after partial hepatectomy, intra-arterial treatment with 3-bromopyruvate and chemoembolization［J］. Clin Exp Metastasis, 2008, 25: 811-817.
［8］ Chen Z, Zhang H, Lu W, et al. Role of mitochondria-associated hexokinase II in cancer cell death induced by 3-bromopyruvate［J］. Biochim Biophys Acta, 2009, 1787: 553-560.
［9］ Kim W, Yoon JH, Jeong JM, et al. Apoptosis-inducing antitumor efficacy of hexokinase II inhibitor in hepatocellular carcinoma［J］. Mol Cancer Ther, 2007, 6: 2554-2562.
［10］ 张海丽， 曾常茜， 郑学仿. 3-溴丙酮酸对人肝癌HepG-2细胞增殖和凋亡的影响［J］. 广西医科大学学报， 2010， 27： 183-187.
［11］ 曾常茜， 吴思宇. 3-溴丙酮酸抗肿瘤作用及机制研究［J］. 中国新药杂志， 2009， 18： 793-796.
［12］ Xu RH, Pelicano H, Zhou Y, et al. Inhibition of glycolysis in cancer cells: A novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia［J］. Cancer Res, 2005, 65: 613-621.
［13］ Geschwind JF, Ko YH, Torbenson MS, et al. Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production［J］. Cancer Res, 2002, 62: 3909-3913.
［14］ Vali M, Liapi E, Kowalski J, et al. Intraarterial therapy with a new potent inhibitor of tumor metabolism（3-bromopyruvate）: identification of therapeutic dose and method of injection in an animal model of liver cancer［J］. J Vasc Interv Radiol, 2007, 18: 95-101.